Integration-deficient lentiviral vectors: A slow coming of age

Molecular Therapy

Volumn 17, Issue 8, 2009, Pages 1316-1332

  Wanisch, Klaus ^a   Yáñez Muñoz, Rafael J ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 9; CD34 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120; GRANULOCYTE COLONY STIMULATING FACTOR; INTEGRATION DEFICIENT LENTIVARUS VECTOR; LENTIVIRUS VECTOR; RETROVIRUS VECTOR; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; VIRUS DNA; ZINC FINGER NUCLEASE; ZINC FINGER PROTEIN;

CELL CYCLE ARREST; CELLULAR IMMUNITY; DNA CLEAVAGE; DNA INTEGRATION; DNA TRANSPOSITION; DOUBLE STRANDED DNA BREAK; GENE CONVERSION; GENE DISRUPTION; GENE EXPRESSION; GENE MUTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOPHILIA B; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMORAL IMMUNITY; IN VITRO GENE TRANSFER; IN VIVO GENE TRANSFER; LONG TERMINAL REPEAT; MUTAGENESIS; NONHUMAN; RETROVIRUS; REVERSE TRANSCRIPTION; REVIEW; RNA INTERFERENCE; TRANSCRIPTION REGULATION; TRANSIENT EXPRESSION; VACCINATION; VIRAL GENE DELIVERY SYSTEM; VIRUS GENE; VIRUS INFECTIVITY; VIRUS RECOMBINATION; VIRUS REPLICATION;

ANIMALS; GENETIC VECTORS; HUMANS; INTEGRASES; LENTIVIRUS; MUTATION; TRANSDUCTION, GENETIC;

EID: 68249112926     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2009.122     Document Type: Review

References (150)

1. Naldini, L, Blömer, U, Gage, FH, Trono, D and Verma, IM (1996). Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 93: 11382-11388.
2. Shimada, T, Fujii, H, Mitsuya, H and Nienhuis, AW (1991). Targeted and highly efficient gene transfer into CD4+ cells by a recombinant human immunodeficiency virus retroviral vector. J Clin Invest 88: 1043-1047.
3. Zufferey, R, Dull, T, Mandel, RJ, Bukovsky, A, Quiroz, D, Naldini, L et al. (1998). Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72: 9873-9880.
4. Blömer, U, Naldini, L, Kafri, T, Trono, D, Verma, IM and Gage, FH (1997). Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J Virol 71: 6641-6649.
5. Abordo-Adesida, E, Follenzi, A, Barcia, C, Sciascia, S, Castro, MG, Naldini, L et al. (2005). Stability of lentiviral vector-mediated transgene expression in the brain in the presence of systemic antivector immune responses. Hum Gene Ther 16: 741-751.
6. Yang, Y, Nunes, FA, Berencsi, K, Furth, EE, Gönczöl, E and Wilson, JM (1994). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 91: 4407-4411.
7. Chirmule, N, Propert, K, Magosin, S, Qian, Y, Qian, R and Wilson, J (1999). Immune responses to adenovirus and adeno-associated virus in humans. Gene Ther 6: 1574-1583.
8. Mastakov, MY, Baer, K, Symes, CW, Leichtlein, CB, Kotin, RM and During, MJ (2002). Immunological aspects of recombinant adeno-associated virus delivery to the mammalian brain. J Virol 76: 8446-8454.
9. Mingozzi, F, Maus, MV, Hui, DJ, Sabatino, DE, Murphy, SL, Rasko, JE et al. (2007). CD8(+) T-cell responses to adeno-associated virus capsid in humans. Nat Med 13: 419-422.
10. Murphy, SL, Li, H, Mingozzi, F, Sabatino, DE, Hui, DJ, Edmonson, SA et al. (2009). Diverse IgG subclass responses to adeno-associated virus infection and vector administration. J Med Virol 81: 65-74.
11. Naldini, L, Blömer, U, Gallay, P, Ory, D, Mulligan, R, Gage, FH et al. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267.
12. Miyoshi, H, Takahashi, M, Gage, FH and Verma, IM (1997). Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc Natl Acad Sci USA 94: 10319-10323.
13. Kafri, T, Blömer, U, Peterson, DA, Gage, FH and Verma, IM (1997). Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet 17: 314-317.
14. Hacein-Bey-Abina, S, von Kalle, C, Schmidt, M, Le Deist, F, Wulffraat, N, McIntyre, E et al. (2003). A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348: 255-256.
15. Suzuki, Y and Craigie, R (2007). The road to chromatin - nuclear entry of retroviruses. Nat Rev Microbiol 5: 187-196.
16. Follenzi, A, Ailles, LE, Bakovic, S, Geuna, M and Naldini, L (2000). Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet 25: 217-222.
17. Zennou, V, Petit, C, Guetard, D, Nerhbass, U, Montagnier, L and Charneau, P (2000). HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101: 173-185.
18. Hindmarsh, P and Leis, J (1999). Retroviral DNA integration. Microbiol Mol Biol Rev 63: 836-843.
19. Craigie, R (2001). HIV integrase, a brief overview from chemistry to therapeutics. J Biol Chem 276: 23213-23216.
20. Wu, Y (2008). The second chance story of HIV-1 DNA: Unintegrated? Not a problem! Retrovirology 5: 61.
21. Hsu, TW, Sabran, JL, Mark, GE, Guntaka, RV and Taylor, JM (1978). Analysis of unintegrated avian RNA tumor virus double-stranded DNA intermediates. J Virol 28: 810-818.
22. Shank, PR, Hughes, SH, Kung, HJ, Majors, JE, Quintrell, N, Guntaka, RV et al. (1978). Mapping unintegrated avian sarcoma virus DNA: termini of linear DNA bear 300 nucleotides present once or twice in two species of circular DNA. Cell 15: 1383-1395.
23. Gianni, AM, Smotkin, D and Weinberg, RA (1975). Murine leukemia virus: detection of unintegrated double-stranded DNA forms of the provirus. Proc Natl Acad Sci USA 72: 447-451.
24. Li, L, Olvera, JM, Yoder, KE, Mitchell, RS, Butler, SL, Lieber, M et al. (2001). Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection. EMBO J 20: 3272-3281.
25. Cara, A, Cereseto, A, Lori, F and Reitz, MS (1996). HIV-1 protein expression from synthetic circles of DNA mimicking the extrachromosomal forms of viral DNA. J Biol Chem 271: 5393-5397.
26. Delelis, O, Petit, C, Leh, H, Mbemba, G, Mouscadet, JF and Sonigo, P (2005). A novel function for spumaretrovirus integrase: An early requirement for integrase-mediated cleavage of 2 LTR circles. Retrovirology 2: 31.
27. Grandgenett, DP and Vora, AC (1985). Site-specific nicking at the avian retrovirus LTR circle junction by the viral pp32 DNA endonuclease. Nucleic Acids Res 13: 6205-6221.
28. Wu, Y (2004). HIV-1 gene expression: Lessons from provirus and non-integrated DNA. Retrovirology 1: 13.
29. Cara, A and Klotman, ME (2006). Retroviral E-DNA: Persistence and gene expression in nondividing immune cells. J Leukoc Biol 80: 1013-1017.
30. Sarkis, C, Philippe, S, Mallet, J and Serguera, C (2008). Non-integrating lentiviral vectors. Curr Gene Ther 8: 430-437.
31. Philpott, NJ and Thrasher, AJ (2007). Use of nonintegrating lentiviral vectors for gene therapy. Hum Gene Ther 18: 483-489.
32. Frankel, AD and Young, JA (1998). HIV-1: Fifteen proteins and an RNA. Annu Rev Biochem 67: 1-25.
33. Wiskerchen, M and Muesing, MA (1995). Human immunodeficiency virus type 1 integrase: Effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells. J Virol 69: 376-386.
34. Butler, SL, Johnson, EP and Bushman, FD (2002). Human immunodeficiency virus cDNA metabolism: Notable stability of two-long terminal repeat circles. J Virol 76: 3739-3747.
35. Pierson, TC, Kieffer, TL, Ruff, CT, Buck, C, Gange, SJ and Siliciano, RF (2002). Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication. J Virol 76: 4138-4144.
36. Gillim-Ross, L, Cara, A and Klotman, ME (2005). HIV-1 extrachromosomal 2-LTR circular DNA is long-lived in human macrophages. Viral Immunol 18: 190-196.
37. Sharkey, M, Triques, K, Kuritzkes, DR and Stevenson, M (2005). In vivo evidence for instability of episomal human immunodeficiency virus type 1 cDNA. J Virol 79: 5203-5210.
38. Shoemaker, C, Goff, S, Gilboa, E, Paskind, M, Mitra, SW and Baltimore, D (1980). Structure of a cloned circular Moloney murine leukemia virus DNA molecule containing an inverted segment: Implications for retrovirus integration. Proc Natl Acad Sci USA 77: 3932-3936.
39. Lin, FL, Sperle, K and Sternberg, N (1984). Model for homologous recombination during transfer of DNA into mouse L cells: Role for DNA ends in the recombination process. Mol Cell Biol 4: 1020-1034.
40. Seidman, MM (1987). Intermolecular homologous recombination between transfected sequences in mammalian cells is primarily nonconservative. Mol Cell Biol 7: 3561-3565.
41. Miller, MD, Wang, B and Bushman, FD (1995). Human immunodeficiency virus type 1 preintegration complexes containing discontinuous plus strands are competent to integrate in vitro. J Virol 69: 3938-3944.
42. Bayer, M, Kantor, B, Cockrell, A, Ma, H, Zeithaml, B, Li, X et al. (2008). A large U3 deletion causes increased in vivo expression from a nonintegrating lentiviral vector. Mol Ther 16: 1968-1976.
43. Folger, KR, Wong, EA, Wahl, G and Capecchi, MR (1982). Patterns of integration of DNA microinjected into cultured mammalian cells: Evidence for homologous recombination between injected plasmid DNA molecules. Mol Cell Biol 2: 1372-1387.
44. Goubin, G and Hill, M (1979). Monomer and multimer covalently closed circular forms of Rous sarcoma virus DNA. J Virol 29: 799-804.
45. Hartikka, J, Sawdey, M, Cornefert-Jensen, F, Margalith, M, Barnhart, K, Nolasco, M et al. (1996). An improved plasmid DNA expression vector for direct injection into skeletal muscle. Hum Gene Ther 7: 1205-1217.
46. Jonsson, CB, Donzella, GA, Gaucan, E, Smith, CM and Roth, MJ (1996). Functional domains of Moloney murine leukemia virus integrase defined by mutation and complementation analysis. J Virol 70: 4585-4597.
47. Katz, RA, Mack, JP, Merkel, G, Kulkosky, J, Ge, Z, Leis, J et al. (1992). Requirement for a conserved serine in both processing and joining activities of retroviral integrase. Proc Natl Acad Sci USA 89: 6741-6745.
48. Cannon, PM, Wilson, W, Byles, E, Kingsman, SM and Kingsman, AJ (1994). Human immunodeficiency virus type 1 integrase: Effect on viral replication of mutations at highly conserved residues. J Virol 68: 4768-4775.
49. Engelman, A, Englund, G, Orenstein, JM, Martin, MA and Craigie, R (1995). Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J Virol 69: 2729-2736.
50. Leavitt, AD, Robles, G, Alesandro, N and Varmus, HE (1996). Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection. J Virol 70: 721-728.
51. Engelman, A (1999). In vivo analysis of retroviral integrase structure and function. Adv Virus Res 52: 411-426.
52. Masuda, T, Kuroda, MJ and Harada, S (1998). Specific and independent recognition of U3 and U5 att sites by human immunodeficiency virus type 1 integrase in vivo. J Virol 72: 8396-8402.
53. Apolonia, L, Waddington, SN, Fernandes, C, Ward, NJ, Bouma, G, Blundell, MP et al. (2007). Stable gene transfer to muscle using non-integrating lentiviral vectors. Mol Ther 15: 1947-1954.
54. Nightingale, SJ, Hollis, RP, Pepper, KA, Petersen, D, Yu, XJ, Yang, C et al. (2006). Transient gene expression by nonintegrating lentiviral vectors. Mol Ther 13: 1121-1132.
55. Moldt, B, Staunstrup, NH, Jakobsen, M, Yáñez-Muñoz, RJ and Mikkelsen, JG (2008). Genomic insertion of lentiviral DNA circles directed by the yeast Flp recombinase. BMC Biotechnol 8: 60.
56. Yáñez-Muñoz, RJ, Balaggan, KS, MacNeil, A, Howe, SJ, Schmidt, M, Smith, AJ et al. (2006). Effective gene therapy with nonintegrating lentiviral vectors. Nat Med 12: 348-353.
57. Markowitz, M, Nguyen, BY, Gotuzzo, E, Mendo, F, Ratanasuwan, W, Kovacs, C et al. (2007). Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: Results of a 48-week controlled study. J Acquir Immune Defic Syndr 46: 125-133.
58. Shimura, K, Kodama, E, Sakagami, Y, Matsuzaki, Y, Watanabe, W, Yamataka, K et al. (2008). Broad antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303/GS-9137). J Virol 82: 764-774.
59. Al-Mawsawi, LQ and Neamati, N (2007). Blocking interactions between HIV-1 integrase and cellular cofactors: An emerging anti-retroviral strategy. Trends Pharmacol Sci 28: 526-535.
60. Jacque, JM and Stevenson, M (2006). The inner-nuclear-envelope protein emerin regulates HIV-1 infectivity. Nature 441: 641-645.
61. Philippe, S, Sarkis, C, Barkats, M, Mammeri, H, Ladroue, C, Petit, C et al. (2006). Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo. Proc Natl Acad Sci USA 103: 17684-17689.
62. Cornu, TI and Cathomen, T (2007). Targeted genome modifications using integrase-deficient lentiviral vectors. Mol Ther 15: 2107-2113.
63. Cockrell, AS and Kafri, T (2007). Gene delivery by lentivirus vectors. Mol Biotechnol 36: 184-204.
64. Vigna, E and Naldini, L (2000). Lentiviral vectors: Excellent tools for experimental gene transfer and promising candidates for gene therapy. J Gene Med 2: 308-316.
65. Reiser, J, Harmison, G, Kluepfel-Stahl, S, Brady, RO, Karlsson, S and Schubert, M (1996). Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc Natl Acad Sci USA 93: 15266-15271.
66. Zufferey, R, Nagy, D, Mandel, RJ, Naldini, L and Trono, D (1997). Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 15: 871-875.
67. Kim, VN, Mitrophanous, K, Kingsman, SM and Kingsman, AJ (1998). Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1. J Virol 72: 811-816.
68. Miyoshi, H, Blömer, U, Takahashi, M, Gage, FH and Verma, IM (1998). Development of a self-inactivating lentivirus vector. J Virol 72: 8150-8157.
69. Dull, T, Zufferey, R, Kelly, M, Mandel, RJ, Nguyen, M, Trono, D et al. (1998). A third-generation lentivirus vector with a conditional packaging system. J Virol 72: 8463-8471.
70. Yáñez-Muñoz, RJ, Foster, E, Yip, P, McMahon, SB, Waddington, S and Antoniou, M (2007). Integration-deficient lentiviral vectors mediate efficient gene transfer to nervous system and muscle. Mol Ther 15: S378.
71. Yu, SF, von Rüden, T, Kantoff, PW, Garber, C, Seiberg, M, Rüther, U et al. (1986). Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc Natl Acad Sci USA 83: 3194-3198.
72. Zaiss, AK, Son, S and Chang, LJ (2002). RNA 3′ readthrough of oncoretrovirus and lentivirus: Implications for vector safety and efficacy. J Virol 76: 7209-7219.
73. Schambach, A, Galla, M, Maetzig, T, Loew, R and Baum, C (2007). Improving transcriptional termination of self-inactivating γ-retroviral and lentiviral vectors. Mol Ther 15: 1167-1173.
74. Arumugam, PI, Scholes, J, Perelman, N, Xia, P, Yee, JK and Malik, P (2007). Improved human β-globin expression from self-inactivating lentiviral vectors carrying the chicken hypersensitive site-4 (cHS4) insulator element. Mol Ther 15: 1863-1871.
75. Zychlinski, D, Schambach, A, Modlich, U, Maetzig, T, Meyer, J, Grassman, E et al. (2008). Physiological promoters reduce the genotoxic risk of integrating gene vectors. Mol Ther 16: 718-725.
76. Kafri, T, van Praag, H, Gage, FH and Verma, IM (2000). Lentiviral vectors: Regulated gene expression. Mol Ther 1: 516-521.
77. Reiser, J, Lai, Z, Zhang, XY and Brady, RO (2000). Development of multigene and regulated lentivirus vectors. J Virol 74: 10589-10599.
78. LaFemina, RL, Schneider, CL, Robbins, HL, Callahan, PL, LeGrow, K, Roth, E et al. (1992). Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells. J Virol 66: 7414-7419.
79. Logan, AC, Haas, DL, Kafri, T and Kohn, DB (2004). Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integration. J Virol 78: 8421-8436.
80. Brussel, A and Sonigo, P (2004). Evidence for gene expression by unintegrated human immunodeficiency virus type 1 DNA species. J Virol 78: 11263-11271.
81. Ma, H and Kafri, T (2004). A single-LTR HIV-1 vector optimized for functional genomics applications. Mol Ther 10: 139-149.
82. Roberts, JD, Bebenek, K and Kunkel, TA (1988). The accuracy of reverse transcriptase from HIV-1. Science 242: 1171-1173.
83. Wain-Hobson, S (1992). Human immunodeficiency virus type 1 quasispecies in vivo and ex vivo. Curr Top Microbiol Immunol 176: 181-193.
84. Apolonia, L, Waddington, SN, Ward, NJ, Philpott, NJ, Collins, MK and Thrasher, AJ (2008). Factor IX expression from non-integrating lentiviral vectors in muscle. Mol Ther 16: S328.
85. Brussel, A and Sonigo, P (2003). Analysis of early human immunodeficiency virus type 1 DNA synthesis by use of a new sensitive assay for quantifying integrated provirus. J Virol 77: 10119-10124.
86. Donehower, LA and Varmus, HE (1984). A mutant murine leukemia virus with a single missense codon in pol is defective in a function affecting integration. Proc Natl Acad Sci USA 81: 6461-6465.
87. Panganiban, AT and Temin, HM (1984). The retrovirus pol gene encodes a product required for DNA integration: Identification of a retrovirus int locus. Proc Natl Acad Sci USA 81: 7885-7889.
88. Hagino-Yamagishi, K, Donehower, LA and Varmus, HE (1987). Retroviral DNA integrated during infection by an integration-deficient mutant of murine leukemia virus is oligomeric. J Virol 61: 1964-1971.
89. Gaur, M and Leavitt, AD (1998). Mutations in the human immunodeficiency virus type 1 integrase D,D(35)E motif do not eliminate provirus formation. J Virol 72: 4678-4685.
90. Lin, Y and Waldman, AS (2001). Capture of DNA sequences at double-strand breaks in mammalian chromosomes. Genetics 158: 1665-1674.
91. Vasquez, KM, Marburger, K, Intody, Z and Wilson, JH (2001). Manipulating the mammalian genome by homologous recombination. Proc Natl Acad Sci USA 98: 8403-8410.
92. Yáñez, RJ and Porter, ACG (1999). Influence of DNA delivery method on gene targeting frequencies in human cells. Somat Cell Mol Genet 25: 27-31.
93. Case, SS, Price, MA, Jordan, CT, Yu, XJ, Wang, L, Bauer, G et al. (1999). Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors. Proc Natl Acad Sci USA 96: 2988-2993.
94. Haas, DL, Case, SS, Crooks, GM and Kohn, DB (2000). Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors. Mol Ther 2: 71-80.
95. Vargas, J, Gusella, GL, Najfeld, V, Klotman, ME and Cara, A (2004). Novel integrase-defective lentiviral episomal vectors for gene transfer. Hum Gene Ther 15: 361-372.
96. Mali, P, Ye, Z, Hommond, HH, Yu, X, Lin, J, Chen, G et al. (2008). Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts. Stem Cells 26: 1998-2005.
97. Mitrophanous, K, Yoon, S, Rohll, J, Patil, D, Wilkes, F, Kim, V et al. (1999). Stable gene transfer to the nervous system using a non-primate lentiviral vector. Gene Ther 6: 1808-1818.
98. Patel, M, Giddings, AM and Olsen, JC (2008). Integration defective EIAV-based lentiviral vector gene transfer to the nasal epithelium of mice. Mol Ther 16: S338.
99. Saenz, DT, Loewen, N, Peretz, M, Whitwam, T, Barraza, R, Howell, KG et al. (2004). Unintegrated lentivirus DNA persistence and accessibility to expression in nondividing cells: Analysis with class I integrase mutants. J Virol 78: 2906-2920.
100. Lu, Y, Stenzel, M, Sodroski, JG and Haseltine, WA (1989). Effects of long terminal repeat mutations on human immunodeficiency virus type 1 replication. J Virol 63: 4115-4119.
101. Jenke, AC, Scinteie, MF, Stehle, IM and Lipps, HJ (2004). Expression of a transgene encoded on a non-viral episomal vector is not subject to epigenetic silencing by cytosine methylation. Mol Biol Rep 31 85-90.
102. Ellis, J (2005). Silencing and variegation of γ-retrovirus and lentivirus vectors. Hum Gene Ther 16: 1241-1246.
103. Pannell, D, Osborne, CS, Yao, S, Sukonnik, T, Pasceri, P, Karaiskakis, A et al. (2000). Retrovirus vector silencing is de novo methylase independent and marked by a repressive histone code. EMBO J 19: 5884-5894.
104. Park, F, Ohashi, K and Kay, MA (2000). Therapeutic levels of human factor VIII and IX using HIV-1-based lentiviral vectors in mouse liver. Blood 96: 1173-1176.
105. Mazarakis, ND, Azzouz, M, Rohll, JB, Ellard, FM, Wilkes, FJ, Olsen, AL et al. (2001). Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum Mol Genet 10: 2109-2121.
106. Loewen, N, Leske, DA, Chen, Y, Teo, WL, Saenz, DT, Peretz, M et al. (2003). Comparison of wild-type and class I integrase mutant-FIV vectors in retina demonstrates sustained expression of integrated transgenes in retinal pigment epithelium. J Gene Med 5: 1009-1017.
107. Fabes, J, Anderson, P, Yáñez-Muñoz, RJ, Thrasher, A, Brennan, C and Bolsover, S (2006). Accumulation of the inhibitory receptor EphA4 may prevent regeneration of corticospinal tract axons following lesion. Eur J Neurosci 23: 1721-1730.
108. Rahim, AA, Wong, AM, Howe, SJ, Buckley, SM, Acosta-Saltos, AD, Elston, KE et al. (2009). Efficient gene delivery to the adult and fetal CNS using pseudotyped non-integrating lentiviral vectors. Gene Ther 16: 509-520.
109. Li, S, Kimura, E, Fall, BM, Reyes, M, Angello, JC, Welikson, R et al. (2005). Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin. Gene Ther 12: 1099-1108.
110. Annoni, A, Brown, BD, Cantore, A, Sergi Sergi, L, Naldini, L and Roncarolo, MG (2009). In vivo delivery of a micro-RNA regulated antigen-encoding transgene induces antigen-specific regulatory T cells and promotes immunological tolerance. Mol Ther 17: S294.
111. Negri, DR, Michelini, Z, Baroncelli, S, Spada, M, Vendetti, S, Buffa, V et al. (2007). Successful immunization with a single injection of non-integrating lentiviral vector. Mol Ther 15: 1716-1723.
112. Karwacz, K, Mukherjee, S, Apolonia, L, Blundell, MP, Bouma, G, Escors, D et al. (2009). Nonintegrating lentivector vaccines stimulate prolonged T-cell and antibody responses and are effective in tumor therapy. J Virol 83: 3094-3103.
113. Vargas, J, Klotman, ME and Cara, A (2008). Conditionally replicating lentiviral-hybrid episomal vectors for suicide gene therapy. Antiviral Res 80: 288-294.
114. Lombardo, A, Genovese, P, Beausejour, CM, Colleoni, S, Lee, YL, Kim, KA et al. (2007). Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat Biotechnol 25: 1298-1306.
115. Staunstrup, NH, Moldt, B, Mátés, L, Villesen, P, Jakobsen, M, Ivics, Z et al. (2009). Hybrid lentivirus-transposon vectors with a random integration profile in human cells. Mol Ther doi:10.1038/mt.2009.10.
116. Butler, SL, Hansen, MS and Bushman, FD (2001). A quantitative assay for HIV DNA integration in vivo. Nat Med 7: 631-634.
117. Takahashi, K, Tanabe, K, Ohnuki, M, Narita, M, Ichisaka, T, Tomoda, K et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
118. Zhang, XB, Beard, BC, Trobridge, GD, Wood, BL, Sale, GE, Sud, R et al. (2008). High incidence of leukemia in large animals after stem cell gene therapy with a HOXB4-expressing retroviral vector. J Clin Invest 118: 1502-1510.
119. Kawai, T, Choi, U, Cardwell, L, DeRavin, SS, Naumann, N, Whiting-Theobald, NL et al. (2007). WHIM syndrome myelokathexis reproduced in the NOD/SCID mouse xenotransplant model engrafted with healthy human stem cells transduced with C-terminus-truncated CXCR4. Blood 109: 78-84.
120. Kawai, T, Choi, U, Changpriroa, C, Berg, K, Lantz, LM and Malech, HL (2008). Human hematopoietic stem cells infected with integration defective lentiviral vector encoding C-terminus truncated hyperfunctional CXCR4 demonstrate enhanced engraftment in NOD/SCID mice. Mol Ther 16: S114.
121. Berger, G, Goujon, C, Darlix, JL and Cimarelli, A (2009). SIVMAC Vpx improves the transduction of dendritic cells with nonintegrative HIV-1-derived vectors. Gene Ther 16: 159-163.
122. Mühlebach, MD, Wolfrum, N, Schüle, S, Tschulena, U, Sanzenbacher, R, Flory, E et al. (2005). Stable transduction of primary human monocytes by simian lentiviral vector PBj. Mol Ther 12: 1206-1216.
123. Kim, D and Rossi, J (2008). RNAi mechanisms and applications. BioTechniques 44: 613-616.
124. Abbas-Terki, T, Blanco-Bose, W, Déglon, N, Pralong, W and Aebischer, P (2002). Lentiviral-mediated RNA interference. Hum Gene Ther 13: 2197-2201.
125. Banasik, MB, Fischer, AJ and McCray, PB Jr (2007). Development of an integrase deficient lentiviral vector for transient shRNA expression in respiratory epithelia. Mol Ther 15: S385.
126. Yáñez, RJ and Porter, ACG (1998). Therapeutic gene targeting. Gene Ther 5: 149-159.
127. Okada, Y, Ueshin, Y, Hasuwa, H, Takumi, K, Okabe, M and Ikawa, M (2009). Targeted gene modification in mouse ES cells using integrase-defective lentiviral vectors. Genesis 47: 217-223.
128. Choulika, A, Perrin, A, Dujon, B and Nicolas, JF (1995). Induction of homologous recombination in mammalian chromosomes by using the I-SceI system of Saccharomyces cerevisiae. Mol Cell Biol 15: 1968-1973.
129. Smih, F, Rouet, P, Romanienko, PJ and Jasin, M (1995). Double-strand breaks at the target locus stimulate gene targeting in embryonic stem cells. Nucleic Acids Res 23: 5012-5019.
130. Epinat, JC, Arnould, S, Chames, P, Rochaix, P, Desfontaines, D, Puzin, C et al. (2003). A novel engineered meganuclease induces homologous recombination in yeast and mammalian cells. Nucleic Acids Res 31: 2952-2962.
131. Kim, YG, Cha, J and Chandrasegaran, S (1996). Hybrid restriction enzymes: Zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci USA 93: 1156-1160.
132. Urnov, FD, Miller, JC, Lee, YL, Beausejour, CM, Rock, JM, Augustus, S et al. (2005). Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435: 646-651.
133. Arnould, S, Perez, C, Cabaniols, JP, Smith, J, Gouble, A, Grizot, S et al. (2007). Engineered I-CreI derivatives cleaving sequences from the human XPC gene can induce highly efficient gene correction in mammalian cells. J Mol Biol 371: 49-65.
134. Perez, EE, Wang, J, Miller, JC, Jouvenot, Y, Kim, KA, Liu, O et al. (2008). Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol 26: 808-816.
135. Cathomen, T and Joung, JK (2008). Zinc-finger nucleases: The next generation emerges. Mol Ther 16: 1200-1207.
136. Calos, MP (2006). The phiC31 integrase system for gene therapy. Curr Gene Ther 6: 633-645.
137. Ivics, Z and Izsvak, Z (2006). Transposons for gene therapy! Curr Gene Ther 6: 593-607.
138. Piechaczek, C, Fetzer, C, Baiker, A, Bode, J and Lipps, HJ (1999). A vector based on the SV40 origin of replication and chromosomal S/MARs replicates episomally in CHO cells. Nucleic Acids Res 27: 426-428.
139. Yates, JL, Warren, N and Sugden, B (1985). Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313: 812-815.
140. Gething, MJ and Sambrook, J (1981). Cell-surface expression of influenza haemagglutinin from a cloned DNA copy of the RNA gene. Nature 293: 620-625.
141. Bischoff, JR, Kirn, DH, Williams, A, Heise, C, Horn, S, Muna, M et al. (1996). An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274: 373-376.
142. Farr, CJ, Bayne, RA, Kipling, D, Mills, W, Critcher, R and Cooke, HJ (1995). Generation of a human X-derived minichromosome using telomere-associated chromosome fragmentation. EMBO J 14: 5444-5454.
143. Humme, S, Reisbach, G, Feederle, R, Delecluse, HJ, Bousset, K, Hammerschmidt, W et al. (2003). The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold. Proc Natl Acad Sci USA 100: 10989-10994.
144. Moens, U, Van Ghelue, M and Johannessen, M (2007). Oncogenic potentials of the human polyomavirus regulatory proteins. Cell Mol Life Sci 64: 1656-1678.
145. Hoshiya, H, Kazuki, Y, Abe, S, Takiguchi, M, Kajitani, N, Watanabe, Y et al. (2009). A highly stable and nonintegrated human artificial chromosome (HAC) containing the 2.4 Mb entire human dystrophin gene. Mol Ther 17: 309-317.
146. Lu, R, Nakajima, N, Hofmann, W, Benkirane, M, Jeang, KT, Sodroski, J et al. (2004). Simian virus 40-based replication of catalytically inactive human immunodeficiency virus type 1 integrase mutants in nonpermissive T cells and monocyte-derived macrophages. J Virol 78: 658-668.
147. Bainbridge, JW, Smith, AJ, Barker, SS, Robbie, S, Henderson, R, Balaggan, K et al. (2008). Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med 358: 2231-2239.
148. Maguire, AM, Simonelli, F, Pierce, EA, Pugh, EN, Mingozzi, F, Bennicelli, J et al. (2008). Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 358: 2240-2248.
149. Hauswirth, WW, Aleman, TS, Kaushal, S, Cideciyan, AV, Schwartz, SB, Wang, L et al. (2008). Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: Short-term results of a phase I trial. Hum Gene Ther 19: 979-990.
150. Hanna, J, Wernig, M, Markoulaki, S, Sun, CW, Meissner, A, Cassady, JP et al. (2007). Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318: 1920-1923.